hs-10296
hansoh pharmaceutical
['apollo', 'pancreatic']
outstanding talk by on therapeutic progress for #hrd in #pancreaticcancer. reversion mutation rare and also indicates platinum resistance. parpi provides lower toxicity. adjuvant trial #apollo and other combination io trials are ongoing. immunologic target = #aacr23 
🗽 #NYC 🩺 #GI #oncologist @MSKCancerCenter #PancreaticCancer #BiliaryCancer #cancer 💜 #fan 🧬 #science #running #26.2 #research #trial #췌장담관암